Vimarsana
Biggest News Aggregation in the World

Page 36 - Shannon Devine News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shannon Devine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shannon Devine Today - Breaking & Trending Today

Ensysce Biosciences, Inc.: Ensysce Biosciences Receives Positive Nasdaq Listing Determination - Vimarsana News

Ensysce Biosciences, Inc.: Ensysce Biosciences Receives Positive Nasdaq Listing Determination

SAN DIEGO, CA / ACCESSWIRE / February 15, 2023 / Ensysce Biosciences, Inc. (the "Company") (NASDAQ:ENSC), a clinical-stage biotech company applying transformative chemistry to improve prescription drug

Engine Gaming and Media Inc.: Engine Gaming Announces Shares for Debt Settlement - Vimarsana News

Engine Gaming and Media Inc.: Engine Gaming Announces Shares for Debt Settlement

NEW YORK, NY / ACCESSWIRE / February 15, 2023 / Engine Gaming and Media, Inc. (GAME) ("Engine" or the "Company") (NASDAQ:GAME)(TSXV:GAME) announces it has entered into shares for debt agreements.The Company

Kaleyra Announces Fourth Quarter 2022 and Full Year 2022 Results - Vimarsana News

Kaleyra Announces Fourth Quarter 2022 and Full Year 2022 Results

Fourth Quarter Highlighted by Record Revenues of $93.7 MillionRecord Full Year 2022 Revenues of $339.2 Million, Up 27% YoYAnnounces Implementation...

Ensysce Biosciences, Inc. Announces Closing of $3.0 Million Registered Direct Offering Priced at-the-Market Under NASDAQ Rules - Vimarsana News

Ensysce Biosciences, Inc. Announces Closing of $3.0 Million Registered Direct Offering Priced at-the-Market Under NASDAQ Rules

SAN DIEGO, CA / ACCESSWIRE / February 7, 2023 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) (the "Company"), a clinical-stage biotech company applying transformative chemistry to improve prescription drug

Ensysce Biosciences, Inc. Announces $3 Million Registered Direct Offering - Vimarsana News

Ensysce Biosciences, Inc. Announces $3 Million Registered Direct Offering

SAN DIEGO, CA / ACCESSWIRE / February 3, 2023 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) (the "Company"), a clinical-stage biotech company applying transformative chemistry to improve prescription drug